Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Teligent Net Profit Margin 2010-2021 | TLGT

Teligent net profit margin from 2010 to 2021. Net profit margin can be defined as net Income as a portion of total sales revenue.
  
Teligent Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2021-06-30 $0.05B $-0.09B -200.00%
2021-03-31 $0.05B $-0.09B -186.00%
2020-12-31 $0.05B $-0.12B -271.11%
2020-09-30 $0.05B $-0.05B -92.16%
2020-06-30 $0.06B $-0.05B -96.36%
2020-03-31 $0.06B $-0.04B -72.88%
2019-12-31 $0.07B $-0.03B -38.46%
2019-09-30 $0.07B $-0.03B -51.52%
2019-06-30 $0.07B $-0.03B -46.97%
2019-03-31 $0.06B $-0.04B -62.50%
2018-12-31 $0.07B $-0.04B -54.55%
2018-09-30 $0.06B $-0.03B -46.67%
2018-06-30 $0.05B $-0.03B -62.26%
2018-03-31 $0.06B $-0.02B -38.18%
2017-12-31 $0.06B $-0.02B -25.00%
2017-09-30 $0.06B $-0.01B -22.22%
2017-06-30 $0.07B $-0.01B -11.76%
2017-03-31 $0.07B $-0.01B -14.93%
2016-12-31 $0.06B $-0.01B -19.05%
2016-09-30 $0.06B $-0.01B -20.97%
2016-06-30 $0.06B $-0.01B -22.41%
2016-03-31 $0.05B $-0.00B -2.00%
2015-12-31 $0.05B $0.01B 15.56%
2015-09-30 $0.05B $0.02B 41.30%
2015-06-30 $0.04B $0.02B 53.66%
2015-03-31 $0.04B $0.01B 34.21%
2014-12-31 $0.03B $0.01B 17.65%
2014-09-30 $0.03B $-0.00B -3.70%
2014-06-30 $0.02B $-0.00B -4.17%
2014-03-31 $0.02B $-0.00B -4.55%
2013-12-31 $0.02B $-0.00B -5.26%
2013-09-30 $0.01B $-0.00B -7.14%
2013-06-30 $0.01B $-0.00B -16.67%
2013-03-31 $0.01B $-0.00B -30.00%
2012-12-31 $0.01B $-0.00B -50.00%
2012-09-30 $0.01B $-0.00B -50.00%
2012-06-30 $0.01B $-0.00B -37.50%
2012-03-31 $0.01B $-0.00B -37.50%
2011-12-31 $0.01B $-0.00B -37.50%
2011-09-30 $0.01B $-0.00B -37.50%
2011-06-30 $0.01B $-0.01B -62.50%
2011-03-31 $0.01B $-0.01B -62.50%
2010-12-31 $0.01B $-0.01B -71.43%
2010-09-30 $0.01B $-0.01B -83.33%
2010-06-30 $0.01B $-0.00B -80.00%
2010-03-31 $0.00B $-0.01B -175.00%
2009-12-31 $0.00B $-0.01B -200.00%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.000B $0.000B
Teligent, Inc. is a specialty generic pharmaceutical company, develops, manufactures and markets topical formulations primarily in the United States. It sells generic pharmaceutical products in topical, injectable, complex and ophthalmic dosage forms. Teligent Inc., formerly known as IGI Laboratories, Inc., is based in Buena, New Jersey.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $19.044B 6.25
Dr Reddy's Laboratories (RDY) India $11.978B 22.92
BridgeBio Pharma (BBIO) United States $4.260B 0.00
Bausch Health Cos (BHC) Canada $3.012B 2.18
Amphastar Pharmaceuticals (AMPH) United States $2.097B 12.61
Supernus Pharmaceuticals (SUPN) United States $1.962B 26.71
Taysha Gene Therapies (TSHA) United States $0.434B 30.29
Personalis (PSNL) United States $0.261B 0.00
Assembly Biosciences (ASMB) United States $0.098B 0.00
Sol-Gel Technologies (SLGL) Israel $0.012B 0.00
Evoke Pharma (EVOK) United States $0.007B 0.00